연구

연구업적

최근 5년 연구업적 현황
연도 2023년 2022년 2021년 2020년 2019년
SCI 논문
발표편수
책임 173편 163편 184편 135편 144편
공동 120편 115편 136편 168편 167편
합계 293편 278편 320편 303편 311편
1441. Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer.
Kim S1, Kim TM, Kim DW, Go H, Keam B, Lee SH, Ku JL, Chung DH, Heo DS.
J Thorac Oncol. 2013 Apr;8(4):415-22. doi: 10.1097/JTO.0b013e318283dcc0. Link
1440. Early response evaluation for recurrent high grade gliomas treated with bevacizumab: a volumetric analysis using diffusion-weighted imaging.
Hwang EJ1, Cha Y, Lee AL, Yun TJ, Kim TM, Park CK, Kim JH, Sohn CH, Park SH, Kim IH, Heo DS, Lee SH, Choi SH.
J Neurooncol. 2013 May;112(3):427-35. doi: 10.1007/s11060-013-1072-z. Epub 2013 Feb 17. Link
1439. Fluorescence in situ hybridization panel for monitoring of minimal residual disease in patients with double minute chromosomes.
Jeon Y1, Kim SY, Kim M, Park HK, Lee SH, See CJ, Kwon J, Lee DS.
Blood Cells Mol Dis. 2013 Nov 7. pii: S1079-9796(13)00237-4. doi: 10.1016/j.bcmd.2013.10.008. [Epub ahead of print] Link
1438. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
Kim M1, Kook H, Park HJ, Ahn HS, Lee KC, Lee KS, Park SK, Lim JY, Kim HK, Han DK, Lee DS; Korean Pediatric MDS Working Party.
Acta Haematol. 2013;130(2):115-21. doi: 10.1159/000347038. Epub 2013 Apr 3. Link
1437. Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Oh B1, Kim TY, Min HJ, Kim M, Kang MS, Huh JY, Kim Y, Lee DS.
Anticancer Drugs. 2013 Jan;24(1):20-31. doi: 10.1097/CAD.0b013e32835a0fbd. Link
1436. In vivo bioluminescence reporter gene imaging for the activation of neuronal differentiation induced by the neuronal activator neurogenin 1 (Ngn1) in neuronal precursor cells.
Oh HJ1, Hwang do W, Youn H, Lee DS.
Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1607-17. doi: 10.1007/s00259-013-2457-0. Epub 2013 Jun 11. Link
1435. Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study.
Yun YH1,?Lee MK,?Park SM,?Kim YA,?Lee WJ,?Lee KS,?Choi JS,?Jung KH,?Do YR,?Kim SY,?Heo DS,?Kim HT,?Park SR.
Ann Oncol.?2013 Feb;24(2):489-94. doi: 10.1093/annonc/mds469. Epub 2012 Oct 30. Link
1434. Factors associated with depression in disease-free stomach cancer survivors.
Han KH1,?Hwang IC,?Kim S,?Bae JM,?Kim YW,?Ryu KW,?Lee JH,?Noh JH,?Sohn TS,?Shin DW,?Yun YH.
J Pain Symptom Manage.?2013 Oct;46(4):511-22. doi: 10.1016/j.jpainsymman.2012.10.234. Epub 2013 Mar 13. Link
1433. Suicide ideation in stomach cancer survivors and possible risk factors.
Choi YN1,?Kim YA,?Yun YH,?Kim S,?Bae JM,?Kim YW,?Ryu KW,?Lee JH,?Noh JH,?Sohn TS.
Support Care Cancer.?2014 Feb;22(2):331-7. doi: 10.1007/s00520-013-1975-4. Epub 2013 Sep 21. Link
1432. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
Kim KI, Kim JW, Lee HJ, Kim BS, Bang SM, Kim I, Oh JM, Yoon SS, Lee JS, Park S, Kim BK.
Am J Hematol. 2013 Feb;88(2):107-12. doi: 10.1002/ajh.23359. Epub 2012 Dec 8. Link